1.Effect of Guiqi Yiyuan Ointment Combined with Cisplatin on Mice with Lewis Lung Cancer Through Endoplasmic Reticulum Stress Pathway and Mitochondrial Apoptosis Pathway
Siqi KONG ; Jintian LI ; Juan LI ; Jianqing LIANG ; Yi ZHANG ; Yue ZHANG ; Chao YUAN
Chinese Journal of Experimental Traditional Medical Formulae 2024;30(20):54-61
		                        		
		                        			
		                        			ObjectiveTo explore the effects of Guiqi Yiyuan ointment combined with cisplatin on mice with Lewis lung cancer through the endoplasmic reticulum stress pathway and mitochondrial apoptosis pathway. MethodFifty SPF male C57BL/6 mice were randomly divided into the model group, cisplatin group (0.005 g·kg-1), and low, medium, and high dose groups of Guiqi Yiyuan ointment combined with cisplatin (0.005+1.6 g·kg-1, 0.005+3.3 g·kg-1, and 0.005+6.6 g·kg-1). Lewis cell suspension was inoculated under the axilla of mice in each group to construct the Lewis lung cancer xenograft mouse model. After continuous administration for 14 days, the mice were sacrificed. The body weight of the mice was measured, and the tumor weight was measured after the tumors were removed. The organ index and tumor inhibition rate were calculated. Hematoxylin-eosin ( HE) staining was used to observe the pathological changes in tumor tissue. Flow cytometry was used to detect the apoptosis rate of tumor cells and the ratio of reactive oxygen species (ROS). Western blot was used to detect the expression of glucose-regulated protein 78 (GRP78), phosphorylated activated protein kinase R-like endoplasmic reticulum kinase (p-PERK), activated transcription factor 4 (ATF4), and apoptosis protein C/EBP homologous protein (CHOP) in the endoplasmic reticulum stress pathway, as well as cysteine aspartate protease-9 (Caspase-9), B-cell lymphoma-2(Bcl-2), and Bcl-2 associated X protein(Bax) in the mitochondrial apoptosis pathway. ResultCompared with those in the model group, the mice in the groups of Guiqi Yiyuan Ointment combined with cisplatin had shinier fur and better mental response status. Tumor mass was reduced in all treatment groups (P<0.05), and tumor inhibition rate was increased in all treatment groups (P<0.05). The thymus and spleen indices of the combined group were increased (P<0.05), and obvious pathological changes were observed in the tumor tissue of all treatment groups, with a gradual decrease in heteromorphism. Destruction of massive tumor tissue was observed in the high-dose combined group, and the apoptosis rate and ROS generation rate of tumor cells were increased in all treatment groups (P<0.05). The protein expression level of Bcl-2 in the tumor tissue gradually decreased (P<0.05), while the protein expression levels of GRP78, p-PERK, ATF4, CHOP, Bax, and Caspase-9 were significantly increased (P<0.05). Compared with the cisplatin group, tumor mass was reduced in the combined group (P<0.05), and tumor inhibition rates in the low and high-dose combined groups were increased (P<0.05). The thymus index, spleen index, apoptosis rate of tumor cells, and ROS ratio in the combined group were significantly increased (P<0.05), while the protein expression levels of GRP78, p-PERK, Bax, and Caspase-9 were increased in the low and high-dose combined groups (P<0.05). The protein expression levels of ATF4 and CHOP were increased in the combined group (P<0.05), while the expression level of Bcl-2 protein gradually decreased (P<0.05). ConclusionGuiqi Yiyuan ointment combined with cisplatin can exert anti-tumor effects in mice with Lewis lung cancer, reduce tumor mass, increase tumor inhibition rate, and induce apoptosis of lung cancer cells. Its mechanism may be related to the regulation of the endoplasmic reticulum stress pathway and mitochondrial apoptosis pathway. 
		                        		
		                        		
		                        		
		                        	
2.Analysis on influencing factors of severity in patients with type 2 diabetes mellitus complicating cerebral small vessel disease
Juan JI ; Ming LI ; Tianchen WU ; Xiaodan SUN ; Xuesu WU ; Wenwen KONG
Chongqing Medicine 2024;53(15):2277-2283
		                        		
		                        			
		                        			Objective To screen and analyze the influencing factors of severity in the patients with type 2 diabetes mellitus (T2DM) complicating cerebral small vessel disease (CSVD).Methods A total of 519 pa-tients with T2DM complicating CSVD admitted and treated in Nanjing Municipal Hospital of Traditional Chi-nese Medicine from June 2018 to May 2023 were selected and divided into the mild group (n=214) and the se-vere group (n=305) according to the CSVD imageological score.The relevant demographic,laboratory and imageological indicators were collected.The influencing factors of T2DM complicating CSVD were screened out by the LASSO and Logistic regression analysis and the predictive model was established.The receiver op-erating characteristic (ROC) curve,goodness of fit evaluation and restricted cubic spline (RCS) fitting curve were drawn to analyze the dose-response relationship between Cys C,albumin/globulin (A/G) ratio with the disease severity.Results The male proportion and age in the severe group were greater than those in the mild group,neutrophil,systemic immune-inflammation index (SII),creatinine (Crea),uric acid (UA),Urea (Ure-a),D-dimer (D-D),lactate dehydrogenase (LDH),adenosine deaminase (ADA),globulin (GLB) and Cys C were higher than those in the mild group,lymphocyte,ALT,High density Lipoprotein-cholesterol (HDL-C),serum cholinesterase (CHE),prealbumin (PAB),and A/G were lower than those in the mild group,and the differences were statistically significant (P<0.05).LASSO and logistic regression analysis showed that the gender,age,A/G and Cys C were the independent influencing factors in the patients with T2DM complicating CSVD.The area under the curve (AUC) of this model was 0.658 (95%CI:0.610-0.706) with goodness of fit (P=0.520).The RCS fitting curves showed that serum Cys C≥0.618 mg/L had a linear relationship with CSVD imageological score (P=0.035),and A/G≥1.268 had a nonlinear relationship with CSVD imageologi-cal score (P=0.007).Conclusion The advanced age,male,increased Cys C level and decreased A/G in the pa-tients with T2DM complicating CSVD are the independent risk factors for the severity of whole brain damage.
		                        		
		                        		
		                        		
		                        	
3.Analysis of characteristic factors and establishment of diagnostic model for hyperuricemia caused renal impairment
Xiaodan SUN ; Tianchen WU ; Ming LI ; Juan JI ; Xuesu WU ; Wenwen KONG
Chongqing Medicine 2024;53(18):2750-2754,2760
		                        		
		                        			
		                        			Objective To screen the characteristic factors of renal impairment occurrence in the patients with hyperuricemia,and to analyze its diagnostic value and establish a diagnostic model.Methods A total of 2405 inpatients with diagnosed hyperuricemia in the Nanjing Municipal Hospital of Traditional Chinese Medi-cine,Nanjing University of Traditional Chinese Medicine from December 2018 to December 2022 were selected and divided into the kidney lesion group (n=1343) and the non-kidney lesion group (n=1062) according to eGFR.The characteristic factors of hyperuricemia caused renal impairment were screened and analyzed by Lasso and logistic regression and the diagnostic model was constructed.The diagnostic value of characteristic factors and diagnostic model were evaluated by the receiver operating characteristic (ROC) curve,and the change rule between the characteristic factors and the results was found by the restricted cubic splines (RCS) fitting.Results The age,uric acid (UA),cystatin-C (Cys-C) and retinol-binding protein (RBP) were the characteristic factors of hyperuricemia caused renal impairment.The combined diagnostic model:logit (P)=-8.70+0.602×age (10 years old)+0.033×UA (10 μmol/L)+0.277×Cys-C (0.1 mg/L)+0.189×RBP (10 mg/L),the area under the ROC curve (AUC) of the combined diagnosis model was 0.893 (95%CI:0.880-0.905).For every 10 μmol/L increase in blood UA,the risk of renal impairment occurrence in hyperurice-mia was increased by 3%;for every 10 years increase in age,the risk of renal impairment occurrence in hyperu-ricemia was increased by 83%;for every 10 mg/L increase in RBP,the risk of kidney damage occurrence of re-nal impairment in hyperuricemia was increased by 21%;for every 0.1 mg/L increase in Cys-C,the risk of re-nal impairment occurrence in hyperuricemia was increased by 32%.Conclusion The combined diagnostic model for whether the renal impairment in the patients with hyperuricemia occurring has good diagnostic val-ue,and Cys-C deserves more attention.
		                        		
		                        		
		                        		
		                        	
4.The Risk and Survival Analysis of Multiple Malignancies in Hematologic Malignancy Patients: A Single Chinese Center Retrospective Study, 2009 through 2017.
Xu-Chang ZHANG ; Lei FAN ; Hua LU ; Si-Xuan QIAN ; Li-Juan CHEN ; Wei XU ; Jian-Yong LI ; Xiao-Yan QU ; Xiao-Li ZHAO
Journal of Experimental Hematology 2023;31(2):389-395
		                        		
		                        			OBJECTIVE:
		                        			To explore the risk and location of multiple malignancies in patients with hematologic malignancies who were followed up for 9 years in Jiangsu Province Hospital and to evaluate the impact of the second primary malignancy on survival of patients.
		                        		
		                        			METHODS:
		                        			The incidence and survival of multiple malignancies in 7 921 patients with hematologic malignancies from 2009 to 2017 were analyzed retrospectively.
		                        		
		                        			RESULTS:
		                        			A total of 180 (2.3%, 180/7 921) patients developed second malignancy, of whom 58 patients were diagnosed with hematologic malignancies as the first primary malignancy, and 98 patients developed hematologic malignancies as second primary malignancy, and the other 24 cases were diagnosed with the second malignancy within 6 months after the first primary malignancy was diagnosed, which was difined as multiple malignancies occurring simultaneously. In 180 patients, 18 cases developed two hematologic malignancies successively, and 11 patients developed more than 3 primary cancers (among them, 2 female patients were diagnosed with 4 primary cancers). Patients with lymphoma and multiple myeloma (MM) as the second primary malignancy had poorer survival than patients with lymphoma and MM as the first primary malignancy. Patients with chronic myeloid leukemia as the second primary malignancy were also associated with inferior overall survival.
		                        		
		                        			CONCLUSION
		                        			In this study, 2.3% of hematologic malignancy patients had multiple mali-gnancies, lymphoma and MM as the second primary malignancy had poor survival.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			East Asian People
		                        			;
		                        		
		                        			Hematologic Neoplasms/complications*
		                        			;
		                        		
		                        			Lymphoma/complications*
		                        			;
		                        		
		                        			Multiple Myeloma/complications*
		                        			;
		                        		
		                        			Neoplasms, Second Primary
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Survival Analysis
		                        			
		                        		
		                        	
5.Primary adrenal NK/T cell lymphoma: a clinicopathologic analysis of six cases.
Sheng Li ZHOU ; Jian Guo WEI ; Bo LI ; Xi Juan WANG ; Zhi Quan GONG ; Pan Hong FAN ; Li Fu WANG ; Rui Jiao ZHAO ; Lei ZHANG ; Ling Fei KONG
Chinese Journal of Pathology 2023;52(7):710-714
		                        		
		                        			
		                        			Objective: To investigate the clinicopathologic features of primary adrenal NK/T cell lymphoma (PANKL). Methods: Six cases of PANKL were collected at Henan Provincial People's Hospital from January 2000 to December 2021. The clinicopathologic features including morphology, immunophenotype, treatment and prognosis were retrospectively analyzed, and relevant literature was reviewed. Results: There were two males and four females. The median age was 63 years (ranged from 57 to 68 years). The tumors involved bilateral adrenal glands in 4 cases and unilateral adrenal gland in 2 cases. The main clinical symptom was low back pain without obvious cause. Serum lactate dehydrogenase (LDH) is elevated in five cases. The imaging feature was rapidly enlarging mass initially confined to unilateral/bilateral adrenal glands. Morphologically, the lymphoid cells were mainly medium-sized with a diffuse growth pattern. Coagulative necrosis and nuclear fragmentation were common. Angioinvasion was seen. Immunophenotypically, the neoplastic cells were positive for CD3, CD56 and TIA-1 while CD5 was negative in 5 cases. All cases were positive for EBER by in situ hybridization with more than 80% proliferative activity by Ki-67. Four cases received chemotherapy, one case underwent surgery, and one case underwent surgery with chemotherapy. Follow-up was done in 5 cases; one case was lost to follow-up. Three patients died with a median survival of 11.6 months (3-42 months). Conclusions: PANKL is rare with highly aggressive clinical presentation and poor prognosis. Accurate diagnosis entails correlation of histomorphology, immunohistochemistry, EBER in situ hybridization and clinical history.
		                        		
		                        		
		                        		
		                        			Male
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Lymphoma, T-Cell, Peripheral/pathology*
		                        			;
		                        		
		                        			Killer Cells, Natural/pathology*
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Immunophenotyping
		                        			
		                        		
		                        	
6.Clinical diagnosis and treatment of hereditary thrombocytopenia and purpura: a report of five cases and literature review.
Xin Bo LYU ; Jie YIN ; Dan Qing KONG ; Hong TIAN ; Yun LI ; Q QYU ; Jian SU ; Li Juan CAO ; Xia BAI ; Zi Qiang YU ; Zhao Yue WANG ; De Pei WU ; Chang Geng RUAN
Chinese Journal of Hematology 2023;44(1):43-47
		                        		
		                        			
		                        			Objective: To report the clinical manifestations and laboratory features of five patients with congenital thrombotic thrombocytopenic purpura (cTTP) and explore its standardized clinical diagnosis and treatment along with a review of literature. Methods: Clinical data of patients, such as age of onset, disease manifestation, personal history, family history, and misdiagnosed disease, were collected. Treatment outcomes, therapeutic effects of plasma infusion, and organ function evaluation were observed. The relationship among the clinical manifestations, treatment outcomes, and ADAMTS13 gene mutation of patients with cTTP was analyzed. Additionally, detection of ADAMTS13 activity and analysis of ADAMTS13 gene mutation were explored. Results: The age of onset of cTTP was either in childhood or adulthood except in one case, which was at the age of 1. The primary manifestations were obvious thrombocytopenia, anemia, and different degrees of nervous system involvement. Most of the patients were initially suspected of having immune thrombocytopenia. Acute cTTP was induced by pregnancy and infection in two and one case, respectively. ADAMTS13 gene mutation was detected in all cases, and there was an inherent relationship between the mutation site, clinical manifestations, and degree of organ injury. Therapeutic or prophylactic plasma transfusion was effective for treating cTTP. Conclusions: The clinical manifestations of cTTP vary among individuals, resulting in frequent misdiagnosis that delays treatment. ADAMTS13 activity detection in plasma and ADAMTS13 gene mutation analysis are important bases to diagnose cTTP. Prophylactic plasma transfusion is vital to prevent the onset of the disease.
		                        		
		                        		
		                        		
		                        			Female
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Blood Component Transfusion
		                        			;
		                        		
		                        			Plasma
		                        			;
		                        		
		                        			Purpura, Thrombotic Thrombocytopenic/therapy*
		                        			;
		                        		
		                        			Mutation
		                        			;
		                        		
		                        			Purpura, Thrombocytopenic, Idiopathic
		                        			;
		                        		
		                        			ADAMTS13 Protein/therapeutic use*
		                        			
		                        		
		                        	
7.A clinical pathway for integrative medicine in the treatment of functional constipation in Hong Kong, China.
Dong-Jue WEI ; Hui-Juan LI ; Zi-Pan LYU ; Ai-Ping LYU ; Zhao-Xiang BIAN ; Linda LD ZHONG
Journal of Integrative Medicine 2023;21(6):550-560
		                        		
		                        			OBJECTIVE:
		                        			Functional constipation (FC) is a common intestinal disease worldwide. Despite the presence of criteria such as Roman IV, there is no standardized diagnosis and treatment algorithm in Hong Kong that combines both Western and Chinese medicine approaches. This study integrates current effective and safe diagnosis and treatment methods for FC and provides a clear and scientific pathway for clinical professionals and patients.
		                        		
		                        			METHODS:
		                        			A systematic search of the PubMed, Cochrane Library, and China National Knowledge Infrastructure databases was performed from their inception to June 30th, 2022, collecting the current evidence about the efficacious integrative management for FC. We organized a meeting of professionals in fields relevant to treatment and management of FC to develop a consensus agreement on clinical pathway process.
		                        		
		                        			RESULTS:
		                        			We developed a clinical pathway for the treatment of FC based on the most recent published guidelines and consultation with experts. This pathway includes a hierarchy of recommendations for every step of the clinical process, including clinical intake, diagnostic examination, recommended labs, diagnostic flowchart, and guidance for selection of therapeutic drugs.
		                        		
		                        			CONCLUSION
		                        			This pathway establishes clinical standards for the diagnosis and treatment of FC using Chinese medicine and Western medicine; it will help to provide high-quality medical services in Hong Kong for patients with FC. Please cite this article as: Wei DJ, Li HJ, Lyu ZP, Lyu AP, Bian ZX, Zhong LL. A clinical pathway for integrative medicine in the treatment of functional constipation in Hong Kong, China. J Integr Med. 2023; 21(6): 550-560.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hong Kong
		                        			;
		                        		
		                        			Integrative Medicine
		                        			;
		                        		
		                        			Critical Pathways
		                        			;
		                        		
		                        			China
		                        			;
		                        		
		                        			Constipation/therapy*
		                        			
		                        		
		                        	
8.A Retrospective Clinical Study on the Correlation between the Theory of Five Movements and Six Climates, and Kidney Deficiency with Governor Vessel Cold Syndrome and Kidney Deficiency Damp-Heat Syndrome in Ankylosing Spondylitis
Juan WU ; Yue LI ; Xiaoping YAN ; Weiping KONG
Journal of Traditional Chinese Medicine 2023;64(21):2208-2215
		                        		
		                        			
		                        			ObjectiveTo explore the relationship between the kidney deficiency and governor vessel cold syndrome and the kidney deficiency damp-heat syndrome in ankylosing spondylitis (AS) patients and the five evolutive phases and six climatic factors of their birth and onset year based on the theory of five movements and six climates (FMSC). MethodsTotally 1791 patients with AS who were admitted to China-Japan Friendship Hospital from September 2010 to September 2020 and met the diagnostic and inclusion criteria were selected in this study. The clinical data were classified into two types of syndromes, kidney deficiency and governor vessel cold syndrome and the kidney deficiency damp-heat syndrome based on the diagnostic criteria of traditional Chinese medicine syndromes. The date of birth and the year of disease onset were converted into FMSC symbols according to the perpetual almanac (《万年历》), and the two could be converted into the terrestrial branch, year evolutive phase, host evolutive phase, guest evolutive phase, host climatic qi, guest climatic qi, celestial manager qi, guest climatic qi adding to fixed host qi, combined analysis of five evolutive phases and six climatic factors, solar terms, and season of the date of birth, as well as the terrestrial branch, year evolutive phase, and celestial manager qi of the year of disease onset. Univariate analyses were performed using the two independent samples t-test or the Mann Whitney U-test, the Pearson (Pearson) χ2 test, or one-way logistic regression analyses, and variables for which statistical significance existed in the one-way analyses were included in the multivariate logistic regression analyses. General conditions, clinical manifestations, physical signs, laboratory indicators [including C reactive protein (CRP), erythrocyte sedimentation rate (ESR), and humans leukocyte antigen B27 (HLA-B27)], measurement (including occipital wall distance, jaw peduncle distance, finger-to-ground distance, thoracic range of motion, and Schober experiment), and distribution of FMSC of birth and disease onset between AS patients with kidney deficiency and governor vessel cold syndrome and with the kidney deficiency damp-heat syndrome were compared, and the association between FMSC and AS patients with kidney deficiency and governor vessel cold syndrome and the kidney deficiency damp-heat syndrome was studied. ResultsThe differences in ESR, CRP, chest mobility, occurrence of achilles tendon enthesitis, and peripheral arthritis between the two groups of patients were statistically significant (P<0.05). Single factor analysis found that taking kidney deficiency and governor vessel cold syndrome as control the following FMSC factors increases the risk of developing kidney deficiency damp-heat syndrome: excess of water in year evolutive phase at birth, excess of wood in host evolutive phase at birth, excess of wood in guest evolutive phase at birth, excess of wood in year evolutive phase of onset, deficiency of metal in year evolutive phase at birth (OR = 2.000, P = 0.004), excess of metal in host evolutive phase at birth (OR = 1.745, P = 0.024) or excess of wood (OR = 1.781, P = 0.023), deficiency of fire in guest evolutive phase at birth (OR = 1.689, P = 0.049) or deficiency of wood (OR = 1.901, P = 0.018) or excess of metal (OR = 2.163, P = 0.004), excess of water in year evolutive phase at the disease onset (OR = 1.880 , P = 0.013) or deficiency of wood (OR = 1.707, P = 0.022). Multivariate logistic regression analysis found that the risk of developing kidney deficiency damp-heat syndrome in AS was increased by deficiency of metal in year evolutive phase at birth, excess of metal in host evolutive phase at birth, higher level of ESR, greater the chest mobility, incidence of concomitant Achilles tendon enthesitis and peripheral arthritis. ConclusionThe year evolutive phase and host evolutive phase at birth play a significant role in the development of kidney deficiency and governor vessel cold syndrome AS. Risk of developing kidney deficiency damp-heat syndrome can be increased by excess of water or deficiency of metal in year evolutive phase at birth, and excess of wood or excess of metal in host evolutive phase at birth and the kidney deficiency damp-heat syndrome in ankylosing spondylitis. 
		                        		
		                        		
		                        		
		                        	
9. Effect of total flavonoids of Rosa rugosa on PI3K/AKT pathway and endoplasmic reticulum stress apoptosis in rats with cerebral ischemia-reperfusion injury
Jing-Rong ZHANG ; Xiu-Shi YU ; Rui-Juan GAO ; Liang-Jing-Yuan KONG ; Pan-Xi SUN ; Chong-Yang ZHANG ; Li-Li WEI ; Jun-Qiang SI ; Li LI
Chinese Pharmacological Bulletin 2023;39(5):896-902
		                        		
		                        			
		                        			 Aim To investigate the effects of total flavonoids from Rosa rugosa (TFR) on cerebral ischemia reperfusion injury (CIRI) in rats, and to investigate whether TFR inhibited neuronal apoptosis by regulating phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) signaling pathway and endoplasmic reticulum stress (ERS) pathways. Methods SD rats were randomly divided into sham operation group, model group, low-dose group (50 mg · kg 
		                        		
		                        		
		                        		
		                        	
		                				10.The effects and mechanisms of trimethylamine-N -oxide on insulin sensitivity in insulin target cells
		                			
		                			Li-juan KONG ; Xiao-jing JIANG ; Ping-ping LI
Acta Pharmaceutica Sinica 2023;58(12):3637-3643
		                        		
		                        			
		                        			 Gut microbial metabolite trimethylamine-
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail